{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:58:32Z","timestamp":1792029512834,"version":"4.4.0"},"reference-count":224,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-OFIRG19may-0002 Duke-NUS-KBrFA\/2023\/0075"],"award-info":[{"award-number":["MOH-OFIRG19may-0002 Duke-NUS-KBrFA\/2023\/0075"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an estimated global prevalence of more than 31%. Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), is a progressive form of MASLD characterized by hepatic steatosis, inflammation, and fibrosis. This review aims to provide a comprehensive analysis of the extrahepatic manifestations of MASH, focusing on chronic diseases related to the cardiovascular, muscular, and renal systems. A systematic review of published studies and literature was conducted to summarize the findings related to the systemic impacts of MASLD and MASH. The review focused on the association of MASLD and MASH with metabolic comorbidities, cardiovascular mortality, sarcopenia, and chronic kidney disease. Mechanistic insights into the concept of lipotoxic inflammatory \u201cspill over\u201d from the MASH-affected liver were also explored. MASLD and MASH are highly associated (50%\u201380%) with other metabolic comorbidities such as impaired insulin response, type 2 diabetes, dyslipidemia, hypertriglyceridemia, and hypertension. Furthermore, more than 90% of obese patients with type 2 diabetes have MASH. Data suggest that in middle-aged individuals (especially those aged 45\u201354), MASLD is an independent risk factor for cardiovascular mortality, sarcopenia, and chronic kidney disease. The concept of lipotoxic inflammatory \u201cspill over\u201d from the MASH-affected liver plays a crucial role in mediating the systemic pathological effects observed. Understanding the multifaceted impact of MASH on the heart, muscle, and kidney is crucial for early detection and risk stratification. This knowledge is also timely for implementing comprehensive disease management strategies addressing multi-organ involvement in MASH pathogenesis.<\/jats:p>","DOI":"10.3389\/fcell.2024.1433857","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:51:03Z","timestamp":1721091063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":227,"title":["Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Reddemma","family":"Sandireddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganya","family":"Sakthivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Behari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhulika","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0002-9343(79)90740-x","article-title":"Fatty liver hepatitis and cirrhosis in obese patients","volume":"67","author":"Adler","year":"1979","journal-title":"Am. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"10718","DOI":"10.3390\/ijms241310718","article-title":"Innovative therapeutic approaches in non-alcoholic fatty liver disease: when knowing your patient is key","volume":"24","author":"Alonso-Pena","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.12998\/wjcc.v8.i20.4688","article-title":"Relationship between non-alcoholic fatty liver disease and coronary heart disease","volume":"8","author":"Arslan","year":"2020","journal-title":"World J. Clin. Cases."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","article-title":"Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease","volume":"20","author":"Ballestri","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/antiox12020516","article-title":"Cardiac hepatopathy: new perspectives on old problems through a prism of endogenous metabolic regulations by hepatokines","volume":"12","author":"Berezin","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.cgh.2017.04.004","article-title":"The long winding road to transplant: how sarcopenia and debility impact morbidity and mortality on the waitlist","volume":"15","author":"Bhanji","year":"","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1194\/jlr.M026013","article-title":"CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice","volume":"54","author":"Bian","year":"2013","journal-title":"J. Lipid. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic liver disease, MASLD and risk of chronic kidney disease","volume":"50","author":"Bilson","year":"2023","journal-title":"Diabetes. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2023.10.039","article-title":"Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH","volume":"80","author":"Boesch","year":"2023","journal-title":"J. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/d41586-020-00194-2","article-title":"The gut microbiome","volume":"577","author":"Brody","year":"2020","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1017\/S0029665113001249","article-title":"Ectopic fat, insulin resistance and non-alcoholic fatty liver disease","volume":"72","author":"Byrne","year":"2013","journal-title":"Proc. Nutr. Soc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20406223211048649","DOI":"10.1177\/20406223211048649","article-title":"The association between NAFLD and risk of chronic kidney disease: a cross-sectional study","volume":"12","author":"Cao","year":"2021","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/toxins10070300","article-title":"Impact of altered intestinal microbiota on chronic kidney disease progression","volume":"10","author":"Castillo-Rodriguez","year":"2018","journal-title":"Toxins (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"592373","DOI":"10.3389\/fendo.2020.592373","article-title":"Harnessing muscle-liver crosstalk to treat nonalcoholic steatohepatitis","volume":"11","author":"Chakravarthy","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/echo.14400","article-title":"Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography","volume":"36","author":"Chang","year":"2019","journal-title":"Echocardiography"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/TP.0000000000002690","article-title":"Immune cell trafficking to the liver","volume":"103","author":"Chaudhry","year":"2019","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"155800","DOI":"10.1016\/j.metabol.2024.155800","article-title":"Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: a community-dwelling cohort study with 20-year follow-up","volume":"153","author":"Choe","year":"2024","journal-title":"Metabolism"},{"key":"B26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","article-title":"Exerkines in health, resilience and disease","volume":"18","author":"Chow","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1097\/HEP.0000000000000706","article-title":"From NAFLD to MASLD: promise and pitfalls of a new definition \u2020","volume":"79","author":"Cusi","year":"2024","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1463-1326.2010.01306.x","article-title":"Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review","volume":"13","author":"Deacon","year":"2011","journal-title":"Diabetes. Obes. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/cells13060481","article-title":"Indoxyl sulfate-induced valve endothelial cell endothelial-to-mesenchymal transition and calcification in an integrin-linked kinase-dependent manner","volume":"13","author":"Delgado-Marin","year":"2024","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3390\/ijms22052639","article-title":"Adipokines, myokines, and hepatokines: crosstalk and metabolic repercussions","volume":"22","author":"de Oliveira Dos Santos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2337\/dc17-2510","article-title":"Hypogonadotropic hypogonadism in men with diabesity","volume":"41","author":"Dhindsa","year":"2018","journal-title":"Diabetes .Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/life13081669","article-title":"Novel anti-inflammatory therapies in coronary artery disease and acute coronary syndromes","volume":"13","author":"Dimitroglou","year":"2023","journal-title":"Life (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E2510","DOI":"10.1210\/jc.2013-4349","article-title":"Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus","volume":"99","author":"Ebert","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/j.jhep.2024.02.001","article-title":"Systemic metabolic Abnormalities: key drivers of complications and mortality in MASLD","volume":"80","author":"Fan Xz","year":"2024","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","article-title":"Skeletal muscle: a brief review of structure and function","volume":"96","author":"Frontera","year":"2015","journal-title":"Calcif. Tissue. Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"B44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.22037\/ghfbb.v15i3.2549","article-title":"Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease","volume":"15","author":"Garbuzenko","year":"2022","journal-title":"Gastroenterol. Hepatol. Bed. Bench."},{"key":"B45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dbi23-0005","article-title":"Adipose signals regulating distal organ health and disease","volume":"73","author":"Gilani","year":"2024","journal-title":"Diabetes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1617805","DOI":"10.1155\/2020\/1617805","article-title":"Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1096\/fj.201802457RR","article-title":"Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis","volume":"33","author":"Gumucio","year":"2019","journal-title":"FASEB J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1291501","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"149406","DOI":"10.1016\/j.bbrc.2023.149406","article-title":"Adiponectin-mediated regulation of the adiponectin cascade in cardiovascular disease: updates","volume":"694","author":"Hafiane","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss","volume":"60","author":"Hallsworth","year":"2011","journal-title":"Gut"},{"key":"B52","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","article-title":"Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease","volume":"58","author":"Hallsworth","year":"2013","journal-title":"J. Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e001852","DOI":"10.1161\/JAHA.115.001852","article-title":"p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes","volume":"4","author":"Han","year":"2015","journal-title":"J. Am. Heart. Assoc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"a029793","DOI":"10.1101\/cshperspect.a029793","article-title":"Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations","volume":"7","author":"Hoffmann","year":"2017","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.33549\/physiolres.934648","article-title":"The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases","volume":"70","author":"Holecek","year":"2021","journal-title":"Physiol. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","article-title":"The degree of hepatic steatosis associates with impaired cardiac and autonomic function","volume":"70","author":"Houghton","year":"2019","journal-title":"J. Hepatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/a-1930-6658","article-title":"Shared mechanisms between cardiovascular disease and NAFLD","volume":"42","author":"Huang","year":"2022","journal-title":"Semin. Liver. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.numecd.2023.08.005","article-title":"Performance of nonalcoholic fatty liver fibrosis score in estimating atherosclerotic cardiovascular disease risk","volume":"33","author":"Huang","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular risk in fatty liver disease: the liver-heart axis-literature review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.jhepr.2021.100316","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7555\/JBR.28.20140045","article-title":"Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database","volume":"28","author":"Jacobs","year":"2014","journal-title":"J. Biomed. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: deciphering communication from the liver","volume":"44","author":"Jensen-Cody","year":"2021","journal-title":"Mol. Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/metabo14030135","article-title":"Exercise alleviates aging of adipose tissue through adipokine regulation","volume":"14","author":"Jia","year":"2024","journal-title":"Metabolites"},{"key":"B67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-024-02092-2","article-title":"Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics","volume":"23","author":"Jiang","year":"2024","journal-title":"Lipids. Health. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e8791","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.3350\/cmh.2022.0358","article-title":"Interaction between sarcopenia and nonalcoholic fatty liver disease","volume":"29","author":"Joo","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5009\/gnl220543","article-title":"Sarcopenic obesity, the possible culprit for nonalcoholic fatty liver disease or fibrosis","volume":"17","author":"Kang","year":"2023","journal-title":"Gut. Liver."},{"key":"B71","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"B73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cld.2023.01.005","article-title":"Clinics in liver disease: update on nonalcoholic steatohepatitis: sarcopenia and nonalcoholic fatty liver disease","volume":"27","author":"Kawaguchi","year":"2023","journal-title":"Clin. Liver. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s12272-022-01419-w","article-title":"Non-alcoholic fatty liver disease and liver secretome","volume":"45","author":"Khan","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2310\/JIM.0b013e31822a29f5","article-title":"Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Koplay","year":"2011","journal-title":"J. Investig. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","article-title":"IL-1beta and IL-18: inflammatory markers or mediators of hypertension?","volume":"171","author":"Krishnan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","article-title":"Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism","volume":"8","author":"Kumar","year":"2008","journal-title":"Cell. Metab."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/s0959-437x(99)00004-0","article-title":"Myostatin and the control of skeletal muscle mass","volume":"9","author":"Lee","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","article-title":"Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2015","journal-title":"J. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients","volume":"68","author":"Lee","year":"2018","journal-title":"J. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ajcn\/nqaa432","article-title":"Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and\/or inherited disorders of one-carbon metabolism: a 3.5-year retrospective cross-sectional study of consecutive patients","volume":"113","author":"Levy","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"B86","first-page":"1","article-title":"Leptin and beyond: an odyssey to the central control of body weight","volume":"84","author":"Li","year":"2011","journal-title":"Yale J. Biol. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2023.12.009","article-title":"Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH)","volume":"105","author":"Li","year":"2023","journal-title":"Kidney. Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/antiox11040755","article-title":"The role of oxidative stress in skeletal muscle myogenesis and muscle disease","volume":"11","author":"Lian","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jhep.2023.05.034","article-title":"Natural history of NASH cirrhosis in liver transplant waitlist registrants","volume":"79","author":"Lim","year":"2023","journal-title":"J. Hepatol."},{"key":"B91","article-title":"Endotext","volume-title":"The role of lipids and lipoproteins in atherosclerosis","author":"Linton","year":"2000"},{"key":"B92","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"key":"B93","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"B96","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.2147\/DMSO.S304357","article-title":"Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease","volume":"14","author":"Machado","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/nu10040440","article-title":"Folate and B12 levels correlate with histological severity in NASH patients","volume":"10","author":"Mahamid","year":"2018","journal-title":"Nutrients"},{"key":"B100","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s40001-024-01708-8","article-title":"Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches","volume":"29","author":"Mahmoudi","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jacc.2021.11.007","article-title":"Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week","volume":"79","author":"Mantovani","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/liv.14044","article-title":"Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis","volume":"39","author":"Mantovani","year":"2019","journal-title":"Liver. Int."},{"key":"B103","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1196033","DOI":"10.3389\/fimmu.2023.1196033","article-title":"Monocyte-endothelial cell interactions in vascular and tissue remodeling","volume":"14","author":"Medrano-Bosch","year":"2023","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.12688\/f1000research.21918.1","article-title":"Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis","volume":"9","author":"Mendez-Sanchez","year":"2020","journal-title":"F1000Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"33255","DOI":"10.1038\/srep33255","article-title":"Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population","volume":"6","author":"Meng","year":"2016","journal-title":"Sci. Rep."},{"key":"B108","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c190029","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr. Physiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.3390\/ijms21155357","article-title":"Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis","volume":"21","author":"Meyer","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","article-title":"Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease","volume":"77","author":"Mitten","year":"2022","journal-title":"J. Hepatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","article-title":"Right ventricular function in heart failure with preserved ejection fraction: a community-based study","volume":"130","author":"Mohammed","year":"2014","journal-title":"Circulation"},{"key":"B113","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J. Cachexia. Sarc. Mus."},{"key":"B114","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cmet.2013.06.017","article-title":"AMPK\u03b11 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration","volume":"18","author":"Mounier","year":"2013","journal-title":"Cell. Metab."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/nutrit\/nuy022","article-title":"Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease","volume":"76","author":"Musa-Veloso","year":"2018","journal-title":"Nutr. Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors","volume":"79","author":"Muzurovic","year":"2022","journal-title":"Hypertension"},{"key":"B119","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2021.02.037","article-title":"Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity","volume":"75","author":"Nachit","year":"2021","journal-title":"J. Hepatol."},{"key":"B120","first-page":"55","article-title":"Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis","volume":"7","author":"Nahandi","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed. Bench."},{"key":"B121","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MOL.0000000000000845","article-title":"Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver-heart crosstalk","volume":"33","author":"Njoku","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut. Microbes."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/hep.30223","article-title":"Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year framingham score","volume":"69","author":"Pais","year":"2019","journal-title":"Hepatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.cir.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/hep.30410","article-title":"The interplay between nonalcoholic fatty liver disease and atherosclerotic heart disease","volume":"69","author":"Patel","year":"2019","journal-title":"Hepatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"155220","DOI":"10.1016\/j.metabol.2022.155220","article-title":"Nonalcoholic fatty liver disease and cardiovascular diseases: a Mendelian randomization study","volume":"133","author":"Peng","year":"2022","journal-title":"Metabolism"},{"key":"B129","doi-asserted-by":"publisher","first-page":"12945","DOI":"10.3390\/ijms222312945","article-title":"Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity","volume":"22","author":"Perdomo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00262.2017","article-title":"The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans","volume":"314","author":"Peter","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J. Hepatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14218\/JCTH.2019.00035","article-title":"Modulating the intestinal microbiota: therapeutic opportunities in liver disease","volume":"8","author":"Philips","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","article-title":"Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications","volume":"304","author":"Pillon","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1037948","DOI":"10.3389\/fendo.2022.1037948","article-title":"GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans","volume":"13","author":"Plomgaard","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B136","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: a narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"B137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","article-title":"Sarcopenia and chronic complications of type 2 diabetes mellitus","volume":"18","author":"Purnamasari","year":"2022","journal-title":"Rev. Diabet. Stud."},{"key":"B140","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/metabo14030153","article-title":"Interleukins: pathogenesis in non-alcoholic fatty liver disease","volume":"14","author":"Rafaqat","year":"2024","journal-title":"Metabolites"},{"key":"B141","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4239\/wjd.v4.i6.234","article-title":"Betatrophin: a liver-derived hormone for the pancreatic \u03b2-cell proliferation","volume":"4","author":"Raghow","year":"2013","journal-title":"World J. Diabetes."},{"key":"B142","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1358863X14557722","article-title":"Carotid artery disease","volume":"19","author":"Ratchford","year":"2014","journal-title":"Vasc. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/hep.32534","article-title":"Relationship between NAFLD and coronary artery disease: a Mendelian randomization study","volume":"77","author":"Ren","year":"2023","journal-title":"Hepatol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.3390\/ijms24098031","article-title":"Uremic toxin indoxyl sulfate promotes macrophage-associated low-grade inflammation and epithelial cell senescence","volume":"24","author":"Ribeiro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu13010015","article-title":"Calorie-restricted mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease","volume":"13","author":"Ristic-Medic","year":"2020","journal-title":"Nutrients"},{"key":"B147","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell Mol. Life. Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s10620-014-3086-6","article-title":"Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis","volume":"59","author":"Roman","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"B151","first-page":"177","article-title":"Clinical definition of sarcopenia","volume":"11","author":"Santilli","year":"2014","journal-title":"Clin. Cases Min. Bone. Metab."},{"key":"B152","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fendo.2014.00004","article-title":"Angiopoietin-like proteins: a comprehensive look","volume":"5","author":"Santulli","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B153","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","article-title":"Chemokines in vascular dysfunction and remodeling","volume":"28","author":"Schober","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver. Int."},{"key":"B156","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/jcm10030385","article-title":"Hepatokines as a molecular transducer of exercise","volume":"10","author":"Seo","year":"2021","journal-title":"J. Clin. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic Messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"key":"B158","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI19081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.numecd.2022.09.003","article-title":"Association between de novo lipogenesis susceptibility genes and coronary artery disease","volume":"32","author":"Simons","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.31204","article-title":"Thyroid hormones and thyromimetics: a new approach to nonalcoholic steatohepatitis?","volume":"72","author":"Sinha","year":"2020","journal-title":"Hepatol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1149618","DOI":"10.3389\/fneur.2023.1149618","article-title":"Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration","volume":"14","author":"Solanki","year":"2023","journal-title":"Front. Neurol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines10030524","article-title":"The role of gut-liver Axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"key":"B165","doi-asserted-by":"publisher","first-page":"925619","DOI":"10.3389\/fnut.2022.925619","article-title":"Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management","volume":"9","author":"Stasi","year":"2022","journal-title":"Front. Nutr."},{"key":"B166","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell. Metab."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.14336\/AD.2022.1208","article-title":"Atherosclerosis: the involvement of immunity, cytokines and cells in pathogenesis, and potential novel therapeutics","volume":"14","author":"Su","year":"2023","journal-title":"Aging. Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1038\/s41598-019-48356-1","article-title":"Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: role of adrenergic overdrive and lipolysis byproducts","volume":"9","author":"Sunaga","year":"2019","journal-title":"Sci. Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat. Genet."},{"key":"B170","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3350\/cmh.2021.0406","article-title":"Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals","volume":"28","author":"Tang","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"B172","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur. Heart J."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"key":"B174","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jhep.2022.06.033","article-title":"Vitamin B(12) and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation","volume":"77","author":"Tripathi","year":"2022","journal-title":"J. Hepatol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/biomedicines9101370","article-title":"Nonalcoholic fatty liver disease and the kidney: a review","volume":"9","author":"Umbro","year":"2021","journal-title":"Biomedicines"},{"key":"B178","doi-asserted-by":"publisher","first-page":"155694","DOI":"10.1016\/j.metabol.2023.155694","article-title":"Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: a Multicenter Observational Study","volume":"148","author":"Valenzuela-Vallejo","year":"2023","journal-title":"Metabolism"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1210\/jc.2007-2524","article-title":"Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men","volume":"93","author":"van der Meer","year":"","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/eurheartj\/ehn207","article-title":"The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function","volume":"29","author":"van der Meer","year":"","journal-title":"Eur. Heart J."},{"key":"B181","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jhep.2018.01.023","article-title":"New insights into NAFLD and subclinical coronary atherosclerosis","volume":"68","author":"VanWagner","year":"2018","journal-title":"J. Hepatol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"132","DOI":"10.21037\/hbsn-23-569","article-title":"Shrinking fat, healing liver: unlocking the metabolic dysfunction associated steatohepatitis puzzle","volume":"13","author":"Venkatesh","year":"2024","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"B183","doi-asserted-by":"publisher","first-page":"e17320","DOI":"10.7759\/cureus.17320","article-title":"The troubling link between non-alcoholic fatty liver disease (NAFLD) and extrahepatic cancers (EHC)","volume":"13","author":"Venniyoor","year":"2021","journal-title":"Cureus"},{"key":"B184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/intechopen.114832","article-title":"Dietary determinants of metabolic syndrome: focus on the obesity and metabolic dysfunction-associated steatotic liver disease (MASLD)","volume-title":"Metabolic syndrome - lifestyle and biological risk factors intechopen","author":"Verma Mkt","year":"2024"},{"key":"B185","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cld.1007","article-title":"The role of life style modifications in comprehensive non-alcoholic fatty liver disease treatment","volume":"17","author":"Viveiros","year":"2021","journal-title":"Clin. Liver. Dis. Hob."},{"key":"B188","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","author":"Walker","year":"2014","journal-title":"Adv. Clin. Chem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s12072-023-10624-8","article-title":"Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease","volume":"18","author":"Wang","year":"2024","journal-title":"Hepatol. Int."},{"key":"B190","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/heartjnl-2012-302972","article-title":"Serum gamma-glutamyltransferase and the risk of heart failure in men and women in Finland","volume":"99","author":"Wang","year":"2013","journal-title":"Heart"},{"key":"B192","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/ATVBAHA.111.240457","article-title":"\u0393-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men","volume":"32","author":"Wannamethee","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"e029873","DOI":"10.1161\/JAHA.123.029873","article-title":"Serum metabolites are associated with HFpEF in biopsy-proven nonalcoholic fatty liver disease","volume":"12","author":"Wegermann","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40273-022-01140-y","article-title":"The economic burden of non-alcoholic steatohepatitis: a systematic review","volume":"40","author":"Witkowski","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"B196","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"812610","DOI":"10.3389\/fendo.2022.812610","article-title":"The role of the intestinal microbiota in nonalcoholic steatohepatitis","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B198","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/hep.32728","article-title":"The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study","volume":"77","author":"Xie","year":"2023","journal-title":"Hepatol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"E292","DOI":"10.1152\/ajpendo.00101.2017","article-title":"Fibroblast growth factor 21: a regulator of metabolic disease and health span","volume":"313","author":"Xie","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B200","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","article-title":"Role of leptin and adiponectin in insulin resistance","volume":"417","author":"Yadav","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"B201","doi-asserted-by":"publisher","first-page":"e072489","DOI":"10.1136\/bmjopen-2023-072489","article-title":"Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study","volume":"13","author":"Yan","year":"2023","journal-title":"BMJ Open"},{"key":"B202","doi-asserted-by":"publisher","first-page":"115011","DOI":"10.1016\/j.biopha.2023.115011","article-title":"Coronary microvascular dysfunction and cardiovascular disease: pathogenesis, associations and treatment strategies","volume":"164","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1120085","DOI":"10.3389\/fcvm.2022.1120085","article-title":"Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B204","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health. Aging."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/cells9091970","article-title":"Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy","volume":"9","author":"Yoshida","year":"2020","journal-title":"Cells"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"","journal-title":"Liver. Int."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"","journal-title":"J. Hepatol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"e0352","DOI":"10.1097\/HC9.0000000000000352","article-title":"The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease","volume":"8","author":"Younossi","year":"","journal-title":"Hepatol. Commun."},{"key":"B210","doi-asserted-by":"publisher","first-page":"e31692","DOI":"10.1097\/MD.0000000000031692","article-title":"A pooled analysis of the association between sarcopenia and osteoporosis","volume":"101","author":"Yu","year":"2022","journal-title":"Med. Baltim."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2174\/0929867325666180313105949","article-title":"Homocysteine and hyperhomocysteinaemia","volume":"26","author":"Zaric","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B212","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell. Commun. Signal."},{"key":"B213","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Zeng","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1288856","DOI":"10.3389\/fmicb.2024.1288856","article-title":"Bacteroides and NAFLD: pathophysiology and therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","article-title":"Trimethylamine-N-Oxide promotes vascular calcification through activation of NLRP3 (Nucleotide-Binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-\u03baB (nuclear factor \u03baB) signals","volume":"40","author":"Zhang","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s10741-019-09809-x","article-title":"A review of fibroblast growth factor 21 in diabetic cardiomyopathy","volume":"24","author":"Zhang","year":"2019","journal-title":"Heart Fail Rev."},{"key":"B217","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s40001-022-00958-8","article-title":"The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study","volume":"27","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"3000605231177191","DOI":"10.1177\/03000605231177191","article-title":"PPAR-alpha\/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: a network meta-analysis","volume":"51","author":"Zhang","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"B219","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","article-title":"TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients","volume":"21","author":"Zhao","year":"","journal-title":"Cardiovasc. Diabetol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13578-022-00856-w","article-title":"New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction","volume":"12","author":"Zhao","year":"","journal-title":"Cell Biosci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","article-title":"The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases","volume":"14","author":"Zhen","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B222","doi-asserted-by":"publisher","first-page":"387","DOI":"10.62347\/KMSA5983","article-title":"Non-alcoholic fatty liver disease: pathogenesis and models","volume":"16","author":"Zhong","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"107249","DOI":"10.1016\/j.vph.2023.107249","article-title":"Two sides of the same coin: non-alcoholic fatty liver disease and atherosclerosis","volume":"154","author":"Zhu","year":"2023","journal-title":"Vasc. Pharmacol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"769069","DOI":"10.3389\/fendo.2021.769069","article-title":"Efficacy and safety of GLP-1 receptor agonists in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1433857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:57:49Z","timestamp":1732409869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1433857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":224,"alternative-id":["10.3389\/fcell.2024.1433857"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2024.1433857","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"article-number":"1433857"}}